<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="brief-report">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochem Biophys Res Commun</journal-id>
      <journal-title-group>
        <journal-title>Biochemical and Biophysical Research Communications</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-291X</issn>
      <issn pub-type="epub">1090-2104</issn>
      <publisher>
        <publisher-name>Academic Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2989445</article-id>
      <article-id pub-id-type="pmid">20934404</article-id>
      <article-id pub-id-type="publisher-id">YBBRC25733</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbrc.2010.10.010</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>ChREBP regulates <italic>Pdx-1</italic> and other glucose-sensitive genes in pancreatic β-cells</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>da Silva Xavier</surname>
            <given-names>Gabriela</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Gao</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Qian</surname>
            <given-names>Qingwen</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rutter</surname>
            <given-names>Guy A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leclerc</surname>
            <given-names>Isabelle</given-names>
          </name>
          <email>i.leclerc@imperial.ac.uk</email>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff>Section of Cell Biology, Division of Diabetes, Endocrinology &amp; Metabolism, Department of Medicine, Faculty of Medicine, Imperial College London, UK</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Corresponding author. Address: Section of Cell Biology, Department of Medicine, South Kensington Campus, Sir Alexander Fleming Building, Imperial College London, London SW7 2AZ, UK. Fax: +44 (0) 207 594 3351. <email>i.leclerc@imperial.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <day>12</day>
        <month>11</month>
        <year>2010</year>
      </pub-date>
      <volume>402</volume>
      <issue>2-2</issue>
      <fpage>252</fpage>
      <lpage>257</lpage>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>9</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2010 Elsevier Inc.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="graphical">
        <title>Research highlights</title>
        <p>► ChREBP silencing enhances glucose-responsive gene expression in MIN6 β-cells. ► ChREBP modulation of <italic>Pdx-1</italic> gene expression might be indirect. ► ChREBP over-expression decreases Pdx-1, MafA, Ins1, Ins2 and GcK mRNA levels in mouse pancreatic islets of Langerhans.</p>
      </abstract>
      <abstract>
        <p>Carbohydrate responsive element-binding protein (ChREBP) is a transcription factor whose expression and activity are increased in pancreatic β-cells maintained at elevated glucose concentrations. We show here that ChREBP inactivation in clonal pancreatic MIN6 β-cells results in an increase in <italic>Pdx-1</italic> expression at low glucose and to a small, but significant, increase in <italic>Ins2</italic>, <italic>GcK</italic> and <italic>MafA</italic> gene expression at high glucose concentrations. Conversely, adenovirus-mediated over-expression of ChREBP in mouse pancreatic islets results in decreases in Pdx-1, MafA, Ins1, Ins2 and GcK mRNA levels. These data suggest that strategies to reduce ChREBP activity might protect against β-cell dysfunction in type 2 diabetes.</p>
      </abstract>
      <kwd-group>
        <title>Abbreviations</title>
        <kwd>ARNT, aryl hydrocarbon receptor nuclear translocator</kwd>
        <kwd>ChREBP, carbohydrate responsive element-binding protein</kwd>
        <kwd>ChIP, chromatin immunoprecipitation</kwd>
        <kwd>ChoRE, carbohydrate-responsive element</kwd>
        <kwd>FAS, fatty acid synthase</kwd>
        <kwd>GcK, glucokinase</kwd>
        <kwd>GFP, green fluorescent protein</kwd>
        <kwd>HIF, hypoxia inducible factor</kwd>
        <kwd>L-PK, L-type pyruvate kinase</kwd>
        <kwd>Pdx-1, pancreatic and duodenum homeobox-1</kwd>
        <kwd>siRNA, small interfering RNA</kwd>
        <kwd>SREBP-1c, sterol regulatory response-element-binding protein-1c</kwd>
        <kwd>USF, upstream stimulatory factor</kwd>
      </kwd-group>
      <kwd-group>
        <title>Keywords</title>
        <kwd>ChREBP</kwd>
        <kwd>Pdx-1</kwd>
        <kwd>MafA</kwd>
        <kwd>Insulin</kwd>
        <kwd>Glucokinase</kwd>
        <kwd>Gene expression</kwd>
        <kwd>Pancreatic β-cells</kwd>
        <kwd>MIN6</kwd>
        <kwd>Islets of Langerhans</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>Pancreatic β-cell glucolipotoxicity <xref rid="b0005" ref-type="bibr">[1]</xref> is considered to play a significant role in the pathogenesis of type 2 diabetes. Carbohydrate responsive element-binding protein (ChREBP) is a member of the basic helix–loop–helix family of transcription factors and transactivates glucose-responsive genes by binding to DNA as a heterodimer with Max-like protein X1 at a well-defined carbohydrate-responsive element (ChoRE) <xref rid="b0010 b0015 b0020 b0025" ref-type="bibr">[2–5]</xref>. In the liver, ChREBP is responsible for converting excess carbohydrate to fatty acids for long-term storage <xref rid="b0030" ref-type="bibr">[6]</xref>. Mice deleted for both alleles of ChREBP display diminished rates of hepatic glycolysis and lipogenesis resulting in high liver glycogen content, low plasma free fatty acid levels and reduced adipose tissue mass <xref rid="b0035" ref-type="bibr">[7]</xref>. Loss of ChREBP in leptin-null <italic>ob</italic>/<italic>ob</italic> mice protects against obesity <xref rid="b0035 b0040" ref-type="bibr">[7,8]</xref>.</p>
      <p>We, and others, have previously shown that, in pancreatic β-cells, ChREBP is activated by high glucose and is responsible for the induction of the lipogenic genes fatty acid synthase (FAS) and L-type pyruvate kinase (L-PK) <xref rid="b0045 b0050" ref-type="bibr">[9,10]</xref>, and the proapoptotic gene <italic>Txnip</italic> <xref rid="b0055 b0060" ref-type="bibr">[11,12]</xref>. ChREBP also represses aryl hydrocarbon receptor nuclear translocator/hypoxia inducible factor 1-β (ARNT/HIF1-β) <xref rid="b0065" ref-type="bibr">[13]</xref> shown recently to be diminished in islets <xref rid="b0070" ref-type="bibr">[14]</xref> and liver <xref rid="b0075" ref-type="bibr">[15]</xref> of type 2 diabetic humans, and necessary for normal β-cell function and repression of hepatic gluconeogenesis. We sought here to investigate the effects of ChREBP silencing and over-expression on other key glucose-responsive genes in pancreatic islet β-cells, namely pancreatic and duodenal homeobox-1 (Pdx-1), MafA, glucokinase (GcK) and insulin, all critical for normal pancreatic β-cell function.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Materials and methods</title>
      <sec sec-type="materials" id="s0015">
        <label>2.1</label>
        <title>Materials</title>
        <p>Primers for siRNA construction and PCR were from MWG Biotech (Milton Keynes, UK). Antibodies were described in <xref rid="b0045" ref-type="bibr">[9]</xref>. Other reagents were from Sigma or Invitrogen.</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Plasmids, adenoviruses and siRNA</title>
        <p>pChREBP and ChREBP siRNA have been described in <xref rid="b0045" ref-type="bibr">[9]</xref>. Adenovirus encoding for ChREBP has been described in <xref rid="b0065" ref-type="bibr">[13]</xref>. Plasmids and adenoviruses encoding GFP-null and constitutively active and dominant negative forms of SREBP-1c were described in <xref rid="b0080" ref-type="bibr">[16]</xref>. pPdx1.Luc<sub>FF</sub>, encoding the 5′ flanking region of the mouse pancreatic duodenum homeobox-1 (<italic>Pdx-1</italic>) gene (−2715 to 0 bp), was generated by PCR from MIN6 cell genomic DNA with the following primers: forward, 5′-ATAT <underline>GG TACC</underline> CTC CAG TAT CAG GGA GGA-3′ (KpnI site underlined); reverse, 5′-TTT <underline>GAGCTC</underline> CCA CCC CAG ATC GCT TTG A-3′ (SacI site underlined) and subcloned into pGL3 basic (Promega). Two point mutations [−106C &gt; A; −102T &gt; G] in the <italic>Pdx-1</italic> promoter were introduced using Quickchange™ (Stratagene) with the following sense primer: 5′-ATG GCT CCA GGG TAA AC<underline>A</underline> ACG <underline>G</underline>GG GGT GCC CCA GAG CCT ATG-3′.</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>MIN6 cell culture and islet of Langerhans isolation</title>
        <p>MIN6 cells were cultured as in <xref rid="b0045" ref-type="bibr">[9]</xref>. Mouse islets of Langerhans were isolated and cultured as in <xref rid="b0065" ref-type="bibr">[13]</xref>.</p>
      </sec>
      <sec id="s0030">
        <label>2.4</label>
        <title>Single cell reporter gene assay</title>
        <p>Intranuclear microinjection of plasmids, antibodies and siRNAs in MIN6 cells were performed at plasmid concentrations of 0.1 (pPdx1.Luc<sub>FF</sub>), and 0.05 (pChREBP, pSREBP-1c, pCMV-RL) mg ml<sup>−1</sup>, and antibody against ChREBP and SREBP at 1 mg ml<sup>−1</sup>, before imaging as described in <xref rid="b0045" ref-type="bibr">[9]</xref>.</p>
      </sec>
      <sec id="s0035">
        <label>2.5</label>
        <title>Real-time RT-PCR</title>
        <p>Total mRNA isolation, cDNA generation and real-time quantitative PCR were performed with primers listed in <xref rid="t0005" ref-type="table">Table 1</xref>, as in <xref rid="b0065" ref-type="bibr">[13]</xref> and according to the manufacturer’s instructions. Levels of mRNA encoding the indicated genes were normalized compared with cyclophilin mRNA and expressed as the fold change over control (null, 3 mM glucose) and presented as the means ± SEM.</p>
      </sec>
      <sec id="s0040">
        <label>2.6</label>
        <title>Chromatin immunoprecipitation assay</title>
        <p>Chromatin immunoprecipitation was performed essentially as described in <xref rid="b0045 b0065" ref-type="bibr">[9,13]</xref>.</p>
      </sec>
      <sec id="s0045">
        <label>2.7</label>
        <title>Statistical analysis</title>
        <p>Data are given as means ± SEM. Comparisons between means were performed by unpaired two-tailed Student’s <italic>t</italic>-test with Bonferroni correction as appropriate, using Microsoft Excel.</p>
      </sec>
    </sec>
    <sec id="s0050">
      <label>3</label>
      <title>Results</title>
      <sec id="s0055">
        <label>3.1</label>
        <title>ChREBP silencing enhances glucose-responsive gene expression in MIN6 pancreatic β-cells</title>
        <p>We have previously shown that ChREBP silencing in pancreatic murine insulinoma MIN6 β-cells improves glucose-stimulated insulin secretion, possibly through a decrease in total triglyceride content <xref rid="b0045" ref-type="bibr">[9]</xref>. Here, we examined the impact of ChREBP silencing by RNA interference on other glucose-responsive genes in MIN6 β-cells. ChREBP knockdown increased the levels of mRNA encoding <italic>MafA</italic>, <italic>GcK</italic> and <italic>Ins2</italic> at high (30 mM) glucose concentrations, whereas ChREBP silencing increased the expression of the <italic>Pdx-1</italic> gene at low (3 mM) glucose concentrations (<xref rid="t0010" ref-type="table">Table 2</xref> and <xref rid="f0005" ref-type="fig">Fig. 1</xref>A). Correspondingly, we observed a similar increase in <italic>Pdx-1</italic> promoter activity at low glucose after ChREBP inhibition by microinjection of a specific anti-ChREBP antibody (<xref rid="f0005" ref-type="fig">Fig. 1</xref>C), while introduction of a ChREBP expression vector by microinjection suppressed the activity of <italic>Pdx-1</italic> promoter at high glucose (<xref rid="f0005" ref-type="fig">Fig. 1</xref>E). By contrast, SREBP1-c inactivation or over-expression was without effect on <italic>Pdx-1</italic> promoter activity or mRNA levels (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B, D and F).</p>
      </sec>
      <sec id="s0060">
        <label>3.2</label>
        <title>ChREBP modulation of <italic>Pdx-1</italic> gene expression might be indirect</title>
        <p>We next sought to identify the region on the <italic>Pdx-1</italic> promoter responsive to ChREBP repression. No consensus ChoRE exists on the <italic>Pdx-1</italic> promoter, but a proximal E-box, located at −105 bp (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A) is highly conserved between species, is protected in DNAse footprints, and has been proposed to confer β-cell specificity to the <italic>Pdx-1</italic> promoter <xref rid="b0085" ref-type="bibr">[17]</xref>. Up to now, it has been thought that this site predominantly binds USF, since mutations abolishing the binding of the latter factor impair the activity of the <italic>Pdx-1</italic> promoter, whereas over-expression of a dominant-negative USF2 reduces both <italic>Pdx-1</italic> promoter activity as well as Pdx-1 mRNA and protein levels <xref rid="b0085 b0090" ref-type="bibr">[17,18]</xref>. Indeed, mutation of this site abolished both the glucose response and the repressive effect of ChREBP of the <italic>Pdx-1</italic> reporter construct (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B). However, neither ChREBP, USF2 nor SREBP-1c binding could be detected to the proximal (−260 to +1) region of the promoter by chromatin immunoprecipitation (<xref rid="f0010" ref-type="fig">Fig. 2</xref>C). By contrast, and as previously reported <xref rid="b0045" ref-type="bibr">[9]</xref>, ChREBP binding was readily detectable on the proximal L-PK promoter at elevated glucose concentrations (<xref rid="f0010" ref-type="fig">Fig. 2</xref>C, bottom panel). We also used this approach to screen a further 11 E-boxes lying in the Pdx-1 promoter region between −2.7 and −0.26 kb (<xref rid="f0015" ref-type="fig">Fig. 3</xref>) but could not reveal evidence for ChREBP (not shown).</p>
      </sec>
      <sec id="s0065">
        <label>3.3</label>
        <title>Adenovirus-mediated over-expression of ChREBP inhibits glucose-responsive gene expression in isolated mouse islets of Langerhans</title>
        <p>We next examined the effects of ChREBP over-expression on the levels of mRNAs encoding the above glucose-responsive genes in intact islets of Langerhans. Mouse islets were transduced either with a null adenovirus encoding GFP only or with an adenovirus encoding full length wild-type ChREBP <xref rid="b0065" ref-type="bibr">[13]</xref>. ChREBP over-expression resulted in a decrease in the levels of the mRNA encoding <italic>Pdx-1</italic>, <italic>MafA</italic> and <italic>GcK</italic> at both low and high glucose concentrations, and <italic>Ins1</italic> and <italic>Ins2</italic> at low glucose concentrations only (<xref rid="f0020" ref-type="fig">Fig. 4</xref>).</p>
      </sec>
    </sec>
    <sec id="s0070">
      <label>4</label>
      <title>Discussion</title>
      <sec id="s0075">
        <label>4.1</label>
        <title>Defining a role for ChREBP in glucose-induced pancreatic β-cell dysfunction and diabetes</title>
        <p>ChREBP is emerging as an important transcription factor in the pathogenesis of obesity and diabetes and their complications. Indeed, ChREBP is now strongly implicated in the pathogenesis of fatty liver disease and insulin resistance <xref rid="b0040 b0095" ref-type="bibr">[8,19]</xref> acting to induce lipogenic genes. Very recently, ChREBP was proposed to contribute to the development of diabetic nephropathy through the induction of HIF1-α in glomerular mesangial cells <xref rid="b0100 b0105" ref-type="bibr">[20,21]</xref> In the pancreatic β-cell, ChREBP activation by high glucose results in increases in triglyceride content and a reduction in glucose-stimulated insulin secretion <xref rid="b0045 b0065" ref-type="bibr">[9,13]</xref>. We show here that, in addition to the direct effects on L-PK, FAS, Txnip and ARNT promoters previously reported <xref rid="b0045 b0050 b0060 b0065" ref-type="bibr">[9,10,12,13]</xref> ChREBP also inhibits the expression of several other key β-cell genes, namely <italic>Pdx-1</italic>, <italic>MafA</italic>, <italic>GcK</italic> and <italic>insulin</italic>.</p>
      </sec>
      <sec id="s0080">
        <label>4.2</label>
        <title>Regulation of <italic>Pdx-1</italic> gene expression by ChREBP</title>
        <p>We show firstly that ChREBP over-expression, both in MIN6 β-cells and pancreatic islets, inhibits <italic>Pdx</italic>-1 gene expression at high glucose concentrations, and that ChREBP inactivation, achieved either by RNA silencing or antibody microinjection into single cells, increases <italic>Pdx-1</italic> expression at low glucose concentrations. Although ChREBP has been shown to possess intrinsic repressive capabilities <xref rid="b0065 b0110" ref-type="bibr">[13,22]</xref>, we were unable to demonstrate direct binding of ChREBP <italic>in vivo</italic> despite scanning the obvious E-boxes, by extensive ChIP assays, at either low or high glucose concentrations (see <xref rid="f0015" ref-type="fig">Fig. 3</xref>). We have considered the possibility that an indirect effect of changes in intracellular lipid content could explain the effects of ChREBP on <italic>Pdx-1</italic> gene expression, but this would appear to be unlikely given the absence of effects of either inactivation of endogenous SREBP-1c or over-expression of the activated nuclear fragment of SREBP-1c on <italic>Pdx-1</italic> promoter activity or mRNA levels (<xref rid="f0005" ref-type="fig">Fig. 1</xref>B, D and F), despite well-documented effects of these manoeuvres on cellular triglyceride content <xref rid="b0080 b0115 b0120" ref-type="bibr">[16,23,24]</xref>. One possible explanation for the apparent inhibitory effects of ChREBP on <italic>Pdx-1</italic> gene expression at low glucose concentrations might be that ChREBP normally serves to sequester another activator(s) of <italic>Pdx-1</italic> under these conditions. Translocation of ChREBP to the nucleus at high glucose concentrations, and its activation, either through covalent modification through phosphorylation/dephosphorylation reactions <xref rid="b0125" ref-type="bibr">[25]</xref>, or through an ill-defined mechanism involving the N-terminal LID domain of ChREBP <xref rid="b0130 b0135" ref-type="bibr">[26,27]</xref>, may then release the bound transcriptional activator, allowing the latter to bind to the <italic>Pdx-1</italic> promoter to stimulate transcription.</p>
        <p>It is of note that we were unable here to demonstrate the binding of USF2 at the −105 E-box of the <italic>Pdx-1</italic> promoter. Our ChIP assay using both anti-USF and anti-SREBP antibodies has been validated in this cell type on the FAS promoter <xref rid="b0045" ref-type="bibr">[9]</xref>, making a false negative unlikely. The discrepancy between data obtained from <italic>in vitro</italic> studies and our ChIP assay demonstrates the significance of <italic>in vivo</italic> (live cell) approaches. Further work will be necessary to identify the key transcription factor binding to the β-cell specific regulatory sequences of the proximal <italic>Pdx-1</italic> promoter.</p>
      </sec>
      <sec id="s0085">
        <label>4.3</label>
        <title>Regulation of the insulin genes by ChREBP</title>
        <p>ChREBP silencing in MIN6 cells resulted in a small, but significant, increase in <italic>Ins2</italic> gene expression whereas, in primary islets, ChREBP over-expression only decreased the amount of <italic>Ins1</italic> and <italic>Ins2</italic> mRNAs at low glucose, but not at elevated glucose concentrations. One possible explanation may lie in the extremely long half-life of insulin mRNAs at high glucose concentrations <xref rid="b0140" ref-type="bibr">[28]</xref>, therefore making a decrease in its transcription rate unnoticeable within the time course of these experiments.</p>
      </sec>
    </sec>
    <sec id="s0090">
      <label>5</label>
      <title>Conclusion</title>
      <p>We conclude that ChREBP is a key regulator of adult β-cell phenotype, affecting the expression of critical genes. It therefore seems possible that increases in ChREBP expression, prompted by a diabetic milieu, may exacerbate β-cell dysfunction and accelerate β-cell failure in type 2 diabetes. It would be interesting to know whether a β-cell specific ChREBP knockout mouse would be protected against the development of β-cell failure during the course of some forms of diabetes.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="b0005">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poitout</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>R.P.</given-names>
            </name>
          </person-group>
          <article-title>Glucolipotoxicity: fuel excess and beta-cell dysfunction</article-title>
          <source>Endocr. Rev.</source>
          <volume>29</volume>
          <year>2008</year>
          <fpage>351</fpage>
          <lpage>366</lpage>
          <pub-id pub-id-type="pmid">18048763</pub-id>
        </element-citation>
      </ref>
      <ref id="b0010">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shih</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Towle</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Definition of the carbohydrate response element of the rat S14 gene. Context of the CACGTG motif determines the specificity of carbohydrate regulation</article-title>
          <source>J. Biol. Chem.</source>
          <volume>269</volume>
          <year>1994</year>
          <fpage>9380</fpage>
          <lpage>9387</lpage>
          <pub-id pub-id-type="pmid">8132677</pub-id>
        </element-citation>
      </ref>
      <ref id="b0015">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shih</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Towle</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription</article-title>
          <source>J. Biol. Chem.</source>
          <volume>270</volume>
          <year>1995</year>
          <fpage>21991</fpage>
          <lpage>21997</lpage>
          <pub-id pub-id-type="pmid">7665621</pub-id>
        </element-citation>
      </ref>
      <ref id="b0020">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamashita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Takenoshita</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sakurai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bruick</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Henzel</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Shillinglaw</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Arnot</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Uyeda</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>98</volume>
          <year>2001</year>
          <fpage>9116</fpage>
          <lpage>9121</lpage>
          <pub-id pub-id-type="pmid">11470916</pub-id>
        </element-citation>
      </ref>
      <ref id="b0025">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stoeckman</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Towle</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes</article-title>
          <source>J. Biol. Chem.</source>
          <volume>279</volume>
          <year>2004</year>
          <fpage>15662</fpage>
          <lpage>15669</lpage>
          <pub-id pub-id-type="pmid">14742444</pub-id>
        </element-citation>
      </ref>
      <ref id="b0030">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uyeda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Repa</surname>
              <given-names>J.J.</given-names>
            </name>
          </person-group>
          <article-title>Carbohydrate response element binding protein ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis</article-title>
          <source>Cell Metab.</source>
          <volume>4</volume>
          <year>2006</year>
          <fpage>107</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">16890538</pub-id>
        </element-citation>
      </ref>
      <ref id="b0035">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iizuka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bruick</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Horton</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Uyeda</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>101</volume>
          <year>2004</year>
          <fpage>7281</fpage>
          <lpage>7286</lpage>
          <pub-id pub-id-type="pmid">15118080</pub-id>
        </element-citation>
      </ref>
      <ref id="b0040">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dentin</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Benhamed</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hainault</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Fauveau</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Foufelle</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dyck</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Girard</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Postic</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice</article-title>
          <source>Diabetes</source>
          <volume>55</volume>
          <year>2006</year>
          <fpage>2159</fpage>
          <lpage>2170</lpage>
          <pub-id pub-id-type="pmid">16873678</pub-id>
        </element-citation>
      </ref>
      <ref id="b0045">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>da Silva Xavier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Diraison</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Andreolas</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>ChREBP binding to fatty acid synthase and L-type pyruvate kinase genes is stimulated by glucose in pancreatic beta-cells</article-title>
          <source>J. Lipid Res.</source>
          <volume>47</volume>
          <year>2006</year>
          <fpage>2482</fpage>
          <lpage>2491</lpage>
          <pub-id pub-id-type="pmid">16891625</pub-id>
        </element-citation>
      </ref>
      <ref id="b0050">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wollheim</surname>
              <given-names>C.B.</given-names>
            </name>
          </person-group>
          <article-title>ChREBP rather than USF2 regulates glucose stimulation of endogenous L-pyruvate kinase expression in insulin-secreting cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>32746</fpage>
          <lpage>32752</lpage>
          <pub-id pub-id-type="pmid">12087089</pub-id>
        </element-citation>
      </ref>
      <ref id="b0055">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hui</surname>
              <given-names>S.T.</given-names>
            </name>
            <name>
              <surname>Couto</surname>
              <given-names>F.M.</given-names>
            </name>
            <name>
              <surname>Mungrue</surname>
              <given-names>I.N.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Attie</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Lusis</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Shalev</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes</article-title>
          <source>FASEB J.</source>
          <volume>22</volume>
          <year>2008</year>
          <fpage>3581</fpage>
          <lpage>3594</lpage>
          <pub-id pub-id-type="pmid">18552236</pub-id>
        </element-citation>
      </ref>
      <ref id="b0060">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cha-Molstad</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shalev</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein p300 and histone H4 acetylation in pancreatic beta cells</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>16898</fpage>
          <lpage>16905</lpage>
          <pub-id pub-id-type="pmid">19411249</pub-id>
        </element-citation>
      </ref>
      <ref id="b0065">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noordeen</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Khera</surname>
              <given-names>T.K.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Longbottom</surname>
              <given-names>E.R.</given-names>
            </name>
            <name>
              <surname>Pullen</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>da Silva Xavier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Carbohydrate-responsive element-binding protein (ChREBP) is a negative regulator of ARNT/HIF-1beta gene expression in pancreatic islet beta-cells</article-title>
          <source>Diabetes</source>
          <volume>59</volume>
          <year>2010</year>
          <fpage>153</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">19833882</pub-id>
        </element-citation>
      </ref>
      <ref id="b0070">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gunton</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Kulkarni</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Yim</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Hawthorne</surname>
              <given-names>W.J.</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Roberson</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Ricordi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>O’Connell</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes</article-title>
          <source>Cell</source>
          <volume>122</volume>
          <year>2005</year>
          <fpage>337</fpage>
          <lpage>349</lpage>
          <pub-id pub-id-type="pmid">16096055</pub-id>
        </element-citation>
      </ref>
      <ref id="b0075">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gunton</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Saha</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Patti</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Goldfine</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ruderman</surname>
              <given-names>N.B.</given-names>
            </name>
            <name>
              <surname>Gonzalez</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Kahn</surname>
              <given-names>C.R.</given-names>
            </name>
          </person-group>
          <article-title>Ablation of ARNT/HIF1beta in liver alters gluconeogenesis lipogenic gene expression and serum ketones</article-title>
          <source>Cell Metab.</source>
          <volume>9</volume>
          <year>2009</year>
          <fpage>428</fpage>
          <lpage>439</lpage>
          <pub-id pub-id-type="pmid">19416713</pub-id>
        </element-citation>
      </ref>
      <ref id="b0080">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreolas</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>da Silva Xavier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Diraison</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Varadi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lopez-Casillas</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Foufelle</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of acetyl-CoA carboxylase gene expression by glucose requires insulin release and sterol regulatory element binding protein 1c in pancreatic MIN6 beta-cells</article-title>
          <source>Diabetes</source>
          <volume>51</volume>
          <year>2002</year>
          <fpage>2536</fpage>
          <lpage>2545</lpage>
          <pub-id pub-id-type="pmid">12145168</pub-id>
        </element-citation>
      </ref>
      <ref id="b0085">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Melloul</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Marshak</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cerasi</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of pdx-1 gene expression</article-title>
          <source>Diabetes</source>
          <volume>51</volume>
          <issue>Suppl. 3</issue>
          <year>2002</year>
          <fpage>S320</fpage>
          <lpage>S325</lpage>
          <pub-id pub-id-type="pmid">12475770</pub-id>
        </element-citation>
      </ref>
      <ref id="b0090">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qian</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kaytor</surname>
              <given-names>E.N.</given-names>
            </name>
            <name>
              <surname>Towle</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>L.K.</given-names>
            </name>
          </person-group>
          <article-title>Upstream stimulatory factor regulates Pdx-1 gene expression in differentiated pancreatic beta-cells</article-title>
          <source>Biochem. J.</source>
          <volume>341</volume>
          <issue>Pt. 2</issue>
          <year>1999</year>
          <fpage>315</fpage>
          <lpage>322</lpage>
          <pub-id pub-id-type="pmid">10393088</pub-id>
        </element-citation>
      </ref>
      <ref id="b0095">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iizuka</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Uyeda</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice</article-title>
          <source>Am. J. Physiol. Endocrinol. Metab.</source>
          <volume>291</volume>
          <year>2006</year>
          <fpage>E358</fpage>
          <lpage>E364</lpage>
          <pub-id pub-id-type="pmid">16705063</pub-id>
        </element-citation>
      </ref>
      <ref id="b0100">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isoe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Makino</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mizumoto</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sakagami</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Honjo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Takiyama</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Haneda</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein</article-title>
          <source>Kidney Int.</source>
          <volume>78</volume>
          <year>2010</year>
          <fpage>48</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">20375990</pub-id>
        </element-citation>
      </ref>
      <ref id="b0105">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haase</surname>
              <given-names>V.H.</given-names>
            </name>
          </person-group>
          <article-title>The sweet side of HIF</article-title>
          <source>Kidney Int.</source>
          <volume>78</volume>
          <year>2010</year>
          <fpage>10</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">20551925</pub-id>
        </element-citation>
      </ref>
      <ref id="b0110">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cairo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Merla</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Urbinati</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ballabio</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Reymond</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>WBSCR14 a gene mapping to the Williams–Beuren syndrome deleted region is a new member of the Mlx transcription factor network</article-title>
          <source>Hum. Mol. Genet.</source>
          <volume>10</volume>
          <year>2001</year>
          <fpage>617</fpage>
          <lpage>627</lpage>
          <pub-id pub-id-type="pmid">11230181</pub-id>
        </element-citation>
      </ref>
      <ref id="b0115">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diraison</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Parton</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Foufelle</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Briscoe</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Rutter</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR)</article-title>
          <source>Biochem. J.</source>
          <volume>378</volume>
          <year>2004</year>
          <fpage>769</fpage>
          <lpage>778</lpage>
          <pub-id pub-id-type="pmid">14690455</pub-id>
        </element-citation>
      </ref>
      <ref id="b0120">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Maechler</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Antinozzi</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Herrero</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hagenfeldt-Johansson</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Bjorklund</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wollheim</surname>
              <given-names>C.B.</given-names>
            </name>
          </person-group>
          <article-title>The transcription factor SREBP-1c is instrumental in the development of beta-cell dysfunction</article-title>
          <source>J. Biol. Chem.</source>
          <volume>278</volume>
          <year>2003</year>
          <fpage>16622</fpage>
          <lpage>16629</lpage>
          <pub-id pub-id-type="pmid">12600983</pub-id>
        </element-citation>
      </ref>
      <ref id="b0125">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawaguchi</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Osatomi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kabashima</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Uyeda</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Mechanism for fatty acid “sparing” effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase</article-title>
          <source>J. Biol. Chem.</source>
          <volume>277</volume>
          <year>2002</year>
          <fpage>3829</fpage>
          <lpage>3835</lpage>
          <pub-id pub-id-type="pmid">11724780</pub-id>
        </element-citation>
      </ref>
      <ref id="b0130">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Imamura</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Poungvarin</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module</article-title>
          <source>Diabetes</source>
          <volume>55</volume>
          <year>2006</year>
          <fpage>1179</fpage>
          <lpage>1189</lpage>
          <pub-id pub-id-type="pmid">16644671</pub-id>
        </element-citation>
      </ref>
      <ref id="b0135">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>M.N.</given-names>
            </name>
            <name>
              <surname>O’Callaghan</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Towle</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity</article-title>
          <source>J. Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>24029</fpage>
          <lpage>24038</lpage>
          <pub-id pub-id-type="pmid">18591247</pub-id>
        </element-citation>
      </ref>
      <ref id="b0140">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fred</surname>
              <given-names>R.G.</given-names>
            </name>
            <name>
              <surname>Welsh</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>The importance of RNA binding proteins in preproinsulin mRNA stability</article-title>
          <source>Mol. Cell. Endocrinol.</source>
          <volume>297</volume>
          <year>2009</year>
          <fpage>28</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">18621093</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgments</title>
      <p>Supported by grants from Diabetes UK (BDA:RD04/0002895) and Wellcome Trust (WT082366MA) to I.L., and from grants from the Wellcome Trust (Programme Grant 081958/2/07/Z), The European Union (FP6 “Save Beta”; FP7, “IMIDIA”), and the Medical Research Council (G0401641) to G.A.R.</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>ChREBP is a repressor of <italic>Pdx-1</italic> gene expression in MIN6 cells. (A,B) MIN6 cells were cultured for 48 h in the presence of scrambled or ChREBP siRNA (A), or in the presence of null or SREBP-DN adenoviruses (B), then overnight in 3 mM glucose and finally for 6 h in 3 or 30 mM glucose prior to cell lysis, total RNA extraction and real-time quantitative RT-PCR (see Section <xref rid="s0010" ref-type="sec">2</xref>). (C,D) <italic>Pdx-1</italic> promoter activity was monitored via nuclear and cytoplasmic microinjection of <italic>Pdx-1</italic> promoter–reporter system and anti-ChREBP (C) or anti-SREBP (D) antibodies (1 mg ml<sup>−1</sup>), or control IgG as indicated, before culture at the indicated glucose concentrations for 6 h and luciferase imaging as described in Section <xref rid="s0010" ref-type="sec">2</xref>. (E,F) Pdx-1 promoter activity was monitored as above but after co-microinjection of pChREBP (E) or SREBP-CA (F) plasmids. Data are the means ± SEM of three separate experiments.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>Chromatin immunoprecipitation fails to reveal direct ChREBP binding at the proximal Pdx-1 promoter. (A) DNA sequence of the proximal mouse Pdx-1 promoter showing relevant E-box motifs. Arrows represent the primers used for ChIP assay in (C). (B) Cells were microinjected with either wild-type or mutated pPdx-1.Luc<sub>FF</sub> plus pCMV.RL, plus either empty pcDNA3 or pChREBP as indicated, and incubated and imaged as in <xref rid="f0005" ref-type="fig">Fig. 1</xref>. (C) MIN6 cells were cultured in medium containing 3 mM glucose for 16 h prior to stimulation with media containing 3 or 30 mM glucose for 24 h prior to chromatin immunoprecipitation using the antibodies and primers to amplify either Pdx-1 or L-PK promoter as indicated alongside the figure. Data are representative of three independent experiments.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>Sequences of the primers and E-boxes in the −2.7 kb Pdx-1 promoter probed by ChIP assay. Positions of 5′ and 3′ primers are indicated by arrows and those of E-boxes are highlighted in bold.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0020">
      <label>Fig. 4</label>
      <caption>
        <p>Real-time quantitative PCR analysis of gene expression in mouse islets over-expressing ChREBP. Islets of Langerhans isolated from female CD1 mice aged 12–14 weeks were transduced with either null-GFP or ChREBP adenoviruses (100 MOI) and cultured in 11 mM glucose RPMI media for 48 h and incubation in RPMI media supplemented with 3 or 16.7 mM glucose overnight prior to qRT-PCR as described in methods. Data are means ± SEM from three independent experiments done in triplicates, and normalized to cyclophilin mRNA levels prior to expression as fold change from null infected islets cultured at 3 mM glucose. <sup>*</sup><italic>p</italic> <italic>&lt;</italic> 0.05; <sup>**</sup><italic>p</italic> &lt; 0.01; <sup>***</sup><italic>p</italic> &lt; 0.001.</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <table-wrap id="t0005" position="float">
      <label>Table 1</label>
      <caption>
        <p>Primers used for real-time RT-PCR.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th>mRNA</th>
            <th>Forward primer 5′–3′</th>
            <th>Reverse primer 5′–3′</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>MafA</td>
            <td>CACCACGTGCGCTTGG</td>
            <td>CAGAAAGAAGTCGGGTG</td>
          </tr>
          <tr>
            <td>Pdx-1</td>
            <td>TGGAGCTGGCAGTGATGTTGA</td>
            <td>TCAGAGGCAGATCTGGCCAT</td>
          </tr>
          <tr>
            <td>Ins1</td>
            <td>GAAGCGTGGCATTGTGGAT</td>
            <td>TGGGCCTTAGTTGCAGTAGTTCT</td>
          </tr>
          <tr>
            <td>Ins2</td>
            <td>AGCCCTAAGTGATCCGCTACAA</td>
            <td>CATGTTGAAACAATAACCTGGAAGA</td>
          </tr>
          <tr>
            <td>GcK</td>
            <td>GCTTTTGAGACCCGTTTTGTG</td>
            <td>GCCTTCGGTCCCCAGAGT</td>
          </tr>
          <tr>
            <td>Cyclophilin</td>
            <td>TATCTGCACTGCCAAGACTGA</td>
            <td>CCACAATGCTCATGCCTTCTTTCA</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="t0010" position="float">
      <label>Table 2</label>
      <caption>
        <p>Effects of glucose and ChREBP silencing on mRNA levels in MIN6 cells.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="2">[Glucose]</th>
            <th colspan="2">Scrambled siRNA<hr/></th>
            <th colspan="2">ChREBP siRNA<hr/></th>
          </tr>
          <tr>
            <th>3 mM</th>
            <th>30 mM</th>
            <th>3 mM</th>
            <th>30 mM</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>MafA</td>
            <td>0.0294 ± 0.0002</td>
            <td>0.0332 ± 0.0002<sup>***</sup></td>
            <td>0.0297 ± 0.0002</td>
            <td>0.0395 ± 0.0002<sup>*,¶</sup></td>
          </tr>
          <tr>
            <td>GcK</td>
            <td>0.397 ± 0.0002</td>
            <td>0.927 ± 0.0006<sup>***</sup></td>
            <td>0.386 ± 0.0002</td>
            <td>1.14 ± 0.0001<sup>***,¶</sup></td>
          </tr>
          <tr>
            <td>Ins2</td>
            <td>3.52 ± 0.004</td>
            <td>9.79 ± 0.004<sup>***</sup></td>
            <td>3.48 ± 0.0007<sup>¶</sup></td>
            <td>10.2 ± 0.004<sup>***,¶</sup></td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Culture conditions, total RNA preparation and real-time RT-PCR conditions were as described in <xref rid="f0015" ref-type="fig">Fig. 3</xref>. Data are means ± SEM from three independent experiments performed in triplicates, and normalized to cyclophilin mRNA levels. <sup>*</sup>, <sup>***</sup> indicate <italic>p</italic> &lt; 0.05, 0.0001 for the effect of glucose and <sup>¶</sup> indicates <italic>p</italic> &lt; 0.05, for the effect of ChREBP siRNA.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>